SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-052117
Filing Date
2019-02-26
Accepted
2019-02-26 17:16:02
Documents
1
Group Members
KEVIN FERROVATERA CAPITAL MANAGEMENT LLCVHPM HOLDINGS LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A (AMENDMENT NO. 8) d706036dsc13da.htm SC 13D/A 79874
  Complete submission text file 0001193125-19-052117.txt   81744
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Subject) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86624 | Film No.: 19634507
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O VATERA HOLDINGS LLC 499 PARK AVENUE, 23RD FLOOR NEW YORK NY 10022
Business Address C/O VATERA HOLDINGS LLC 499 PARK AVENUE, 23RD FLOOR NEW YORK NY 10022 212 590 2950
Vatera Healthcare Partners LLC (Filed by) CIK: 0001722413 (see all company filings)

IRS No.: 271020233 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A